Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3lp2 | LP9 | Gag-Pol polyprotein | 2.7.7.49 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3lp2 | LP9 | Gag-Pol polyprotein | 2.7.7.49 | 1.000 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.475 | |
2c31 | ADP | Oxalyl-CoA decarboxylase | 4.1.1.8 | 0.471 | |
3njo | P2M | Abscisic acid receptor PYR1 | / | 0.471 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.471 | |
1z5u | CMP | Class B acid phosphatase | / | 0.468 | |
5cae | COA | Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial | 6.2.1.4 | 0.467 | |
4fxf | ATP | Pyruvate kinase PKM | 2.7.1.40 | 0.466 | |
1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.464 | |
1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.462 | |
2zoz | ET | Transcriptional regulator | / | 0.461 | |
2ji9 | ADP | Oxalyl-CoA decarboxylase | 4.1.1.8 | 0.460 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
2q28 | ADP | Oxalyl-CoA decarboxylase | 4.1.1.8 | 0.458 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.458 | |
2b0q | ADP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.456 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.456 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.455 | |
3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.455 | |
3a1l | 2CC | Cytochrome P450 | / | 0.453 | |
3ujl | A8S | Abscisic acid receptor PYL2 | / | 0.452 | |
4rh1 | 0TT | Spore photoproduct lyase | / | 0.452 | |
3pyz | ANP | Dihydrofolate synthase/folylpolyglutamate synthase | / | 0.451 | |
4lg5 | A1O | Abscisic acid receptor PYL2 | / | 0.451 | |
1f20 | FAD | Nitric oxide synthase, brain | 1.14.13.39 | 0.450 | |
3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.450 | |
4o2z | 046 | Mitogen-activated protein kinase | / | 0.450 | |
4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.449 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.449 | |
3uza | T4G | Adenosine receptor A2a | / | 0.449 | |
1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.448 | |
4plp | NAD | Homospermidine synthase | 2.5.1.44 | 0.448 | |
1wbs | LI2 | Mitogen-activated protein kinase 14 | / | 0.447 | |
2jle | I15 | Reverse transcriptase/RNaseH | / | 0.447 | |
3mp5 | HMG | Hydroxymethylglutaryl-CoA lyase, mitochondrial | 4.1.3.4 | 0.447 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.447 | |
3qak | UKA | Adenosine receptor A2a | / | 0.447 | |
3qeo | LLT | Deoxycytidine kinase | 2.7.1.74 | 0.446 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.445 | |
1nue | GDP | Nucleoside diphosphate kinase B | 2.7.4.6 | 0.444 | |
1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
2azy | CHD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.444 | |
2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
3dej | RXC | Caspase-3 | 3.4.22.56 | 0.444 | |
3hmv | HBT | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.444 | |
3p9t | TCL | Repressor | / | 0.444 | |
1oyn | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
2jib | ADP | Oxalyl-CoA decarboxylase | 4.1.1.8 | 0.442 | |
2zsd | COA | Pantothenate kinase | 2.7.1.33 | 0.442 | |
3jyn | NDP | Quinone oxidoreductase | / | 0.442 | |
5dju | FMN | NPH1-2 | / | 0.442 | |
2olc | ADP | Methylthioribose kinase | 2.7.1.100 | 0.441 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.441 | |
1xng | DND | NH(3)-dependent NAD(+) synthetase | 6.3.1.5 | 0.440 | |
3neg | PYV | Abscisic acid receptor PYL1 | / | 0.440 | |
4a5y | G7X | Kinesin-like protein KIF11 | / | 0.440 | |
4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.440 | |
4phl | PIL | Phosphodiesterase | / | 0.440 | |
5f54 | TMP | Single-stranded-DNA-specific exonuclease | / | 0.440 |